Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
Annals of Surgery|December 11, 2023
Nationwide Outcome after Pancreatoduodenectomy in Patients at very High Risk (ISGPS-D) for Postoperative Pancreatic FistulaRutger T Theijse, Thomas F Stoop, Tessa E Hendriks, et al.
Annals of Surgery|September 18, 2025
The Rise of Robot-Assisted Surgery in the Netherlands: An Overview of its Adoption over the Last DecadeMaurits R Visser, Femke J Amelung, J P Maarten Burbach, et al.
Annals of Surgery|August 1, 2024
Interobserver Variability in the International Study Group for Pancreatic Surgery (ISGPS)-Defined Complications After Pancreatoduodenectomy: An International Cross-Sectional Multicenter StudyTessa E Hendriks, Alberto Balduzzi, Susan van Dieren, et al.
Nature Communications|September 7, 2019
The future of Blue Carbon sciencePeter I Macreadie, Andrea Anton, John A Raven, et al.
The British Journal of Surgery|November 9, 2025
Nationwide outcomes of 1000 robotic pancreatoduodenectomies across the four phases of the learning curveAnouk M L H Emmen, Bram L J van den Broek, Tessa E Hendriks, et al.
Nature Communications|November 10, 2019
Author Correction: The future of Blue Carbon sciencePeter I Macreadie, Andrea Anton, John A Raven, et al.
BMJ Open|May 25, 2022
Effectiveness and cost-effectiveness of dynamic bracing versus standard care alone in patients suffering from osteoporotic vertebral compression fractures: protocol for a multicentre, two-armed, parallel-group randomised controlled trial with 12 months of follow-upAnnemarijn Weber, Stephanie M D Huysmans, Sander M J van Kuijk, et al.
The Science of the Total Environment|November 8, 2023
Evaluating the extent and impact of the extreme Storm Gloria on Posidonia oceanica seagrass meadowsCandela Marco-Méndez, Núria Marbà, Ángel Amores, et al.
The Oncologist|October 28, 2020
Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy RecommendationsBart Koopman, Harry J M Groen, Marjolijn J L Ligtenberg, et al.
Lung Cancer (Amsterdam, Netherlands)|October 3, 2025
Determining the optimal approach to identify osimertinib resistance; the first line osimertinib cohort of the OSIRIS studyJ W T van der Wel, S M Ernst, M Jebbink, et al.
Pageof 13